LifeMD Shareholders Equity Per Share from 2010 to 2024

LFMD Stock  USD 9.70  0.51  5.00%   
LifeMD's Shareholders Equity Per Share is increasing over the years with stable fluctuation. Shareholders Equity Per Share is expected to dwindle to 0.06. During the period from 2010 to 2024 LifeMD Shareholders Equity Per Share annual values regression line had geometric mean of  0.07 and mean square error of  0.07. View All Fundamentals
 
Shareholders Equity Per Share  
First Reported
2010-12-31
Previous Quarter
0.10338758
Current Value
0.0638
Quarterly Volatility
0.27040103
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.9 M, Interest Expense of 2.7 M or Selling General Administrative of 54.3 M, as well as many exotic indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 0.0148 or PTB Ratio of 84.19. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.
  
This module can also supplement LifeMD's financial leverage analysis and stock options assessment as well as various LifeMD Technical models . Check out the analysis of LifeMD Correlation against competitors.

Latest LifeMD's Shareholders Equity Per Share Growth Pattern

Below is the plot of the Shareholders Equity Per Share of LifeMD Inc over the last few years. It is LifeMD's Shareholders Equity Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LifeMD's overall financial position and show how it may be relating to other accounts over time.
Shareholders Equity Per Share10 Years Trend
Pretty Stable
   Shareholders Equity Per Share   
       Timeline  

LifeMD Shareholders Equity Per Share Regression Statistics

Arithmetic Mean0.07
Geometric Mean0.07
Coefficient Of Variation381.52
Mean Deviation0.14
Median0.02
Standard Deviation0.27
Sample Variance0.07
Range1.2147
R-Value0.26
Mean Square Error0.07
R-Squared0.07
Significance0.34
Slope0.02
Total Sum of Squares1.02

LifeMD Shareholders Equity Per Share History

2024 0.0638
2022 -0.22
2021 0.99
2020 0.0948
2019 -0.0998
2017 0.1
2016 -0.0504

About LifeMD Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include LifeMD income statement, its balance sheet, and the statement of cash flows. LifeMD investors use historical funamental indicators, such as LifeMD's Shareholders Equity Per Share, to determine how well the company is positioned to perform in the future. Although LifeMD investors may use each financial statement separately, they are all related. The changes in LifeMD's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on LifeMD's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on LifeMD Financial Statements. Understanding these patterns can help to make the right decision on long term investment in LifeMD. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Shareholders Equity Per Share 0.10  0.06 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LifeMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LifeMD's short interest history, or implied volatility extrapolated from LifeMD options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out the analysis of LifeMD Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for LifeMD Stock analysis

When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
4.499
Quarterly Revenue Growth
0.595
Return On Assets
(0.22)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.